+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Liquid Embolic Materials Market by Product Type (Adhesive, Non Adhesive), Application (Arteriovenous Malformation, Cerebral Aneurysm, Peripheral Vascular Lesions), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6149675
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling the Critical Role and Recent Transformative Technological Advancements of Liquid Embolic Materials in Modern Neurovascular and Vascular Therapies

Liquid embolic materials have emerged as an indispensable component in the interventional radiology and neurosurgical toolkit, offering minimally invasive solutions for occluding unwanted vascular flow in conditions such as arteriovenous malformations and cerebral aneurysms. What began as a niche therapeutic approach has rapidly evolved through advances in polymer science and delivery technologies, reshaping clinical workflows and patient outcomes.

In recent years, the convergence of material innovation with precision imaging and microcatheter systems has enabled practitioners to achieve unprecedented levels of control and predictability during embolization procedures. This introduction provides an essential foundation, highlighting the core principles that underpin liquid embolic therapy, the distinguishing features of adhesive versus non-adhesive formulations, and the expanding repertoire of applications beyond neurovascular targets. As the landscape matures, stakeholders across the value chain-from raw material suppliers to device manufacturers and end users-are redefining therapeutic standards and forging partnerships that will determine the next phase of growth and adoption.

Exploring the Technological and Clinical Shifts Redefining Liquid Embolic Solutions and Driving Innovation to Enhance Patient Outcomes in Vascular Interventions

The liquid embolic market is experiencing a profound transformation driven by breakthroughs in polymer chemistry, imaging-guided delivery, and clinical protocol optimization. Recent developments in glacial acrylic acid copolymer and ethylene vinyl alcohol copolymer formulations have enhanced viscosity control and occlusion permanence, while improvements in n-butyl cyanoacrylate and polidocanol adhesives have reduced the risk of non-target embolization.

Moreover, the integration of real-time fluoroscopic and cone-beam CT modalities has enabled clinicians to visualize embolic agent distribution with greater accuracy, paving the way for more complex lesion treatments. In parallel, ongoing clinical studies are expanding applications into peripheral vascular lesions and novel oncologic indications, thereby broadening the therapeutic footprint. As regulatory bodies refine guidelines around device classification and operator training, the sector stands at a pivotal juncture where collaborative innovation is set to reshape patient-centric care pathways.

Assessing the Multifaceted Impact of New United States Tariff Policies Announced for 2025 on Liquid Embolic Material Manufacturers and Supply Chains

The introduction of new United States tariff measures slated for 2025 has injected considerable complexity into the supply chains of liquid embolic manufacturers. Tariff adjustments on imported raw materials such as specialized copolymers and medical-grade solvents have led to upward cost pressures that are reverberating through production budgets and pricing models.

In response, industry participants are re-evaluating sourcing strategies and exploring nearshoring opportunities to mitigate exposure. Some suppliers have accelerated qualification of domestic polymer production facilities, while others are leveraging long-term procurement agreements to lock in favorable terms. Simultaneously, cost management initiatives are driving investments in process automation and lean manufacturing to preserve margin integrity without compromising product quality. This tariff-driven realignment underscores the importance of strategic agility and supply chain resilience in sustaining market leadership.

Deriving Strategic Insights through Product, Application, End User, and Distribution Channel Segmentation to Inform Market Positioning and Growth Strategies

Analyzing the market through the lens of product type reveals a distinct bifurcation between adhesive and non-adhesive chemistries. Adhesive formulations, especially those based on glacial acrylic acid copolymer and n-butyl cyanoacrylate, continue to command attention for their rapid polymerization kinetics and occlusive efficiency in high-flow arteriovenous malformations. Conversely, the non-adhesive chemistries of ethylene vinyl alcohol copolymer and polidocanol offer enhanced penetration in complex vascular anatomies, enabling controlled embolization in cerebral aneurysms and peripheral vascular lesions.

Application-based segmentation further differentiates market dynamics. Arteriovenous malformation treatments drive high procedural volumes in tertiary care centers, while cerebral aneurysm interventions demand advanced imaging compatibility and specialized delivery sheaths. Peripheral vascular lesions represent a burgeoning growth frontier, requiring robust formulations that balance embolic permanence with vessel wall biocompatibility.

From an end-user perspective, hospitals remain the predominant care setting due to their comprehensive infrastructure and clinical expertise, whereas specialty clinics are gaining traction by offering targeted interventional suites with streamlined workflows. Distribution channels are likewise adapting; direct sales models enable deeper collaboration on clinical training and product customization, while distributor networks extend reach into emerging markets, facilitating local support and rapid order fulfillment.

Unearthing Regional Dynamics across Americas, Europe Middle East and Africa, and Asia Pacific to Identify Emerging Opportunities and Geographical Drivers

The Americas region continues to lead adoption, buoyed by advanced clinical infrastructures, robust reimbursement frameworks, and strong R&D investments. North American centers of excellence are pioneering combination therapies that integrate liquid embolics with adjunctive devices such as flow diverters and bioresorbable scaffolds. In contrast, Latin American markets are characterized by selective uptake driven by budget constraints and evolving regulatory pathways, creating opportunities for value-based pricing and modular training programs.

Europe, Middle East and Africa present a mosaic of regulatory landscapes and healthcare delivery models. Western European nations emphasize stringent safety standards and post-market surveillance, while emerging markets in the Middle East and North Africa are seeking strategic partnerships to build local manufacturing capabilities. Across this region, cross-border clinical trials and harmonized certification efforts are accelerating the adoption curve.

Asia-Pacific stands out for its dual trajectory of rapid urban hospital expansion in China and Japan and growing demand for minimally invasive therapies in Southeast Asia. Domestic manufacturers are leveraging government incentives for advanced medical device production, and collaborative research initiatives between academic centers and industry are fostering next-generation embolic agent development.

Highlighting Competitive Landscape Strengths and Strategic Moves of Leading Liquid Embolic Material Manufacturers Shaping Market Evolution

Leadership in the liquid embolic sector is defined by strategic investments in R&D, clinical collaborations, and targeted acquisitions. Key innovators have established integrated development pipelines that span monomer synthesis through catheter delivery system design, enabling seamless alignment between material properties and procedural requirements. Several top-tier device manufacturers have forged partnerships with academic centers to validate novel copolymer blends in multicenter studies, while niche enterprises are differentiating through specialized formulations tailored to rare vascular pathologies.

Competitive pricing pressures and escalating development costs have also prompted consolidation, as mid-sized players seek sustainability through mergers or by securing venture capital for next-generation product lines. Meanwhile, post-market clinical data and real-world evidence are becoming central to value messaging, with leading companies investing in long-term follow-up registries that underscore safety and efficacy. This dynamic landscape underscores the imperative for continuous innovation and strategic alignment between commercialization, clinical validation, and supply chain resilience.

Formulating Actionable Strategic Recommendations to Enhance Competitive Advantage and Operational Excellence in the Liquid Embolic Materials Sector

To maintain competitive differentiation, industry leaders should prioritize modular platform development that enables rapid iteration of polymer chemistries and delivery profiles. Establishing co-development programs with key opinion leaders will not only de-risk clinical adoption but also accelerate time to market for novel formulations. Furthermore, diversifying supply chains through dual sourcing and regional production hubs can mitigate tariff volatility and foster cost stability.

Operational excellence should be reinforced by implementing advanced analytics in manufacturing quality control, enabling predictive maintenance and enhanced batch consistency. On the commercial front, targeted education initiatives for interventional radiologists and neurosurgeons can be scaled through digital training simulations, reinforcing best practices and driving procedural efficiency. Finally, forging strategic alliances with complementary device providers can create bundled offerings that maximize clinical utility and broaden the value proposition for healthcare providers.

Detailing Rigorous Research Methodology and Data Validation Processes Employed to Ensure Reliability and Accuracy of Market Insights

This analysis is grounded in a multi-tiered research framework combining primary interviews with interventional physicians, materials scientists, and procurement leaders, alongside secondary data drawn from regulatory filings, clinical trial databases, and peer-reviewed journals. Data triangulation techniques were deployed to reconcile discrepancies, ensuring robust validation of market trends and technology adoption curves.

Quantitative insights were derived from a structured survey of hospital purchasing departments and specialty clinic directors, while qualitative depth was provided through in-depth discussions with device development teams and academic collaborators. All findings were subjected to rigorous internal peer review and cross-referenced against regional regulatory agency reports to confirm accuracy. Ultimately, this methodological rigor underpins the reliability of the insights and recommendations presented herein.

Synthesizing Key Findings and Strategic Implications to Provide a Cohesive Outlook on the Liquid Embolic Materials Market Trajectory

In synthesizing the key findings, it is evident that liquid embolic materials are undergoing a significant evolution driven by innovation in polymer chemistry, advances in imaging guidance, and strategic responses to supply chain challenges. Segmentation analysis highlights nuanced growth opportunities across product types and application domains, while regional assessments reveal distinct adoption drivers that demand tailored market entry strategies.

Competitive dynamics underscore the importance of sustained investment in clinical validation and supply chain diversification to counteract tariff pressures. As the sector moves forward, stakeholders who excel in forging strategic partnerships, harnessing real-world evidence, and deploying modular development platforms will be best positioned to shape the next generation of liquid embolic solutions. This cohesive outlook provides a clear roadmap for aligning R&D priorities with evolving clinical needs and market access imperatives.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Adhesive
      • Glacial Acrylic Acid Copolymer
      • N-Butyl Cyanoacrylate
    • Non Adhesive
      • Ethylene Vinyl Alcohol Copolymer
      • Polidocanol
  • Application
    • Arteriovenous Malformation
    • Cerebral Aneurysm
    • Peripheral Vascular Lesions
  • End User
    • Hospitals
    • Specialty Clinics
  • Distribution Channel
    • Direct Sales
    • Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Medtronic plc
  • Stryker Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • W. L. Gore & Associates, Inc.
  • Penumbra, Inc.
  • Merit Medical Systems, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of advanced imaging modalities to improve liquid embolic material precision and outcomes
5.2. Development of biodegradable liquid embolic agents for enhanced patient safety and reduced long term complications
5.3. Emergence of microcatheter compatible formulations to facilitate targeted neurovascular interventions with minimal vessel trauma
5.4. Impact of recent regulatory approvals on market access and commercialization strategies for liquid embolic technologies
5.5. Adoption of cost effective liquid embolic solutions to address budget constraints in emerging healthcare markets
5.6. Growing trend of personalized embolization therapies using AI driven modeling and patient specific hemodynamic data
5.7. Focus on environmental sustainability in liquid embolic material manufacturing to minimize ecological footprint and waste
5.8. Collaboration between device manufacturers and academic institutions to drive innovation in polymer based embolization agents
5.9. Advancements in radiopaque marker integration to enhance intraoperative visualization during embolization procedures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Liquid Embolic Materials Market, by Product Type
8.1. Introduction
8.2. Adhesive
8.2.1. Glacial Acrylic Acid Copolymer
8.2.2. N-Butyl Cyanoacrylate
8.3. Non Adhesive
8.3.1. Ethylene Vinyl Alcohol Copolymer
8.3.2. Polidocanol
9. Liquid Embolic Materials Market, by Application
9.1. Introduction
9.2. Arteriovenous Malformation
9.3. Cerebral Aneurysm
9.4. Peripheral Vascular Lesions
10. Liquid Embolic Materials Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Specialty Clinics
11. Liquid Embolic Materials Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
12. Americas Liquid Embolic Materials Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Liquid Embolic Materials Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Liquid Embolic Materials Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Stryker Corporation
15.3.3. Terumo Corporation
15.3.4. Boston Scientific Corporation
15.3.5. Johnson & Johnson
15.3.6. B. Braun Melsungen AG
15.3.7. W. L. Gore & Associates, Inc.
15.3.8. Penumbra, Inc.
15.3.9. Merit Medical Systems, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. LIQUID EMBOLIC MATERIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. LIQUID EMBOLIC MATERIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. LIQUID EMBOLIC MATERIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. LIQUID EMBOLIC MATERIALS MARKET: RESEARCHAI
FIGURE 24. LIQUID EMBOLIC MATERIALS MARKET: RESEARCHSTATISTICS
FIGURE 25. LIQUID EMBOLIC MATERIALS MARKET: RESEARCHCONTACTS
FIGURE 26. LIQUID EMBOLIC MATERIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIQUID EMBOLIC MATERIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY GLACIAL ACRYLIC ACID COPOLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY GLACIAL ACRYLIC ACID COPOLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY N-BUTYL CYANOACRYLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY N-BUTYL CYANOACRYLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ETHYLENE VINYL ALCOHOL COPOLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ETHYLENE VINYL ALCOHOL COPOLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY POLIDOCANOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY POLIDOCANOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PERIPHERAL VASCULAR LESIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PERIPHERAL VASCULAR LESIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 78. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 79. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 80. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 81. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. CANADA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. MEXICO LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 152. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 153. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. GERMANY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 164. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 165. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. FRANCE LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 188. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 189. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 190. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 191. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. ITALY LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 200. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 201. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 202. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. SPAIN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 248. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 249. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 250. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. DENMARK LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 272. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 273. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 274. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 275. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. QATAR LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 284. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 285. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 286. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. FINLAND LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2018-2024 (USD MILLION)
TABLE 320. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY ADHESIVE, 2025-2030 (USD MILLION)
TABLE 321. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2018-2024 (USD MILLION)
TABLE 322. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY NON ADHESIVE, 2025-2030 (USD MILLION)
TABLE 323. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. EGYPT LIQUID EMBOLIC MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Liquid Embolic Materials Market report include:
  • Medtronic plc
  • Stryker Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • W. L. Gore & Associates, Inc.
  • Penumbra, Inc.
  • Merit Medical Systems, Inc.